Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click
here.
Loading metrics
Open Access
Correction
Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience
Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience